Graphite Bio, Inc.
(NASDAQ GM: GRPH)
Rigrodsky Law, P.A. is investigating Graphite Bio, Inc. (“Graphite”) regarding possible breaches of fiduciary duties and other violations of law related to Graphite’s agreement to merge with LENZ Therapeutics.
(NASDAQ GM: GRPH)
Rigrodsky Law, P.A. is investigating Graphite Bio, Inc. (“Graphite”) regarding possible breaches of fiduciary duties and other violations of law related to Graphite’s agreement to merge with LENZ Therapeutics.